Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Zander

Showing results (171-180 of 225) with videos related to

Pageof 23
Sort By:
Free Radical Biology & Medicine|January 1, 1997
Nontransferrin-bound iron in serum of patients receiving bone marrow transplantsM Dürken, P Nielsen, S Knobel, et al.
Leukemia & Lymphoma|February 1, 1997
Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantationW Krüger, M Stockschläder, I Sobottka, et al.
Annals of Hematology|November 28, 2002
Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulinN Kröger, T Zabelina, H Renges, et al.
Bone Marrow Transplantation|August 10, 2000
Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantationK Kühlcke, F A Ayuk, Z Li, et al.
Blood|November 1, 1996
Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantationH H Euler, A M Marmont, A Bacigalupo, et al.
Gene Therapy|November 9, 2002
A novel 'sort-suicide' fusion gene vector for T cell manipulationB Fehse, O S Kustikova, Z Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Piperazinedione, total body irradiation, and autologous bone marrow transplantation in chronic myelogenous leukemiaL Vellekoop, A R Zander, H M Kantarjian, et al.
Annals of Hematology|May 3, 2003
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemiaN Kröger, M Bornhäuser, G Ehninger, et al.
Leukemia|November 5, 2004
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioningA Shimoni, N Kröger, T Zabelina, et al.
Bone Marrow Transplantation|May 1, 2012
Evaluation of BM cytomorphology after allo-SCT in patients with AMLM Christopeit, K Miersch, E Klyuchnikov, et al.
Pageof 23

Showing results (171-180 of 225) with videos related to

Sort By:
Pageof 23
Free Radical Biology & Medicine|January 1, 1997
Nontransferrin-bound iron in serum of patients receiving bone marrow transplantsM Dürken, P Nielsen, S Knobel, et al.
Leukemia & Lymphoma|February 1, 1997
Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantationW Krüger, M Stockschläder, I Sobottka, et al.
Annals of Hematology|November 28, 2002
Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulinN Kröger, T Zabelina, H Renges, et al.
Bone Marrow Transplantation|August 10, 2000
Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantationK Kühlcke, F A Ayuk, Z Li, et al.
Blood|November 1, 1996
Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantationH H Euler, A M Marmont, A Bacigalupo, et al.
Gene Therapy|November 9, 2002
A novel 'sort-suicide' fusion gene vector for T cell manipulationB Fehse, O S Kustikova, Z Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Piperazinedione, total body irradiation, and autologous bone marrow transplantation in chronic myelogenous leukemiaL Vellekoop, A R Zander, H M Kantarjian, et al.
Annals of Hematology|May 3, 2003
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemiaN Kröger, M Bornhäuser, G Ehninger, et al.
Leukemia|November 5, 2004
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioningA Shimoni, N Kröger, T Zabelina, et al.
Bone Marrow Transplantation|May 1, 2012
Evaluation of BM cytomorphology after allo-SCT in patients with AMLM Christopeit, K Miersch, E Klyuchnikov, et al.
Pageof 23